<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="0" ids="35584">purine</z:chebi> analogue, fludarabine, is of proven efficacy in the treatment of lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The drug appears to be well tolerated with minimal side-effects, and few toxicities have been observed </plain></SENT>
<SENT sid="2" pm="."><plain>A case of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> occurring after therapy with fludarabine is presented and its implications are discussed </plain></SENT>
</text></document>